Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PB) Restructuring Costs (2016 - 2023)

Global Medical REIT (GMRE-PB) has disclosed Restructuring Costs for 9 consecutive years, with $2000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Restructuring Costs fell 97.78% year-over-year to $2000.0, compared with a TTM value of $44000.0 through Dec 2023, down 87.57%, and an annual FY2024 reading of $155000.0, up 252.27% over the prior year.
  • Restructuring Costs was $2000.0 for Q2 2023 at Global Medical REIT, down from $42000.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $168000.0 in Q3 2019 and bottomed at $2000.0 in Q2 2023.
  • Average Restructuring Costs over 5 years is $69705.9, with a median of $62000.0 recorded in 2021.
  • The sharpest move saw Restructuring Costs soared 2140.0% in 2022, then plummeted 97.78% in 2023.
  • Year by year, Restructuring Costs stood at $47000.0 in 2019, then surged by 110.64% to $99000.0 in 2020, then tumbled by 94.95% to $5000.0 in 2021, then skyrocketed by 2140.0% to $112000.0 in 2022, then crashed by 98.21% to $2000.0 in 2023.
  • Business Quant data shows Restructuring Costs for GMRE-PB at $2000.0 in Q2 2023, $42000.0 in Q1 2023, and $112000.0 in Q4 2022.